Lv0
0 积分 2025-09-02 加入
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
2个月前
已完结
Efficacy and Safety of Checkpoint Inhibitors Combined with Bacillus Calmette-Guérin (BCG) in BCG-naïve High-risk Non–muscle-invasive Bladder Cancer: Synthesis of Evidence from the ALBAN, CREST, and POTOMAC Trials
2个月前
已完结
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial
2个月前
已完结
Inhibition of tumor cell macropinocytosis driver DHODH reverses immunosuppression and overcomes anti-PD1 resistance
4个月前
已完结
Intra-tumoral hypoxia promotes CD8+ T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4
4个月前
已完结
B cells disrupt tertiary lymphoid structure formation and suppress anti-tumor immunity
4个月前
已完结
Intravesical Hydrogels as Drug Reservoirs
4个月前
已完结
A comprehensive review on hydrogel materials in urology: Problems, methods, and new opportunities
4个月前
已完结
Recent advances of redox-responsive nanoplatforms for tumor theranostics
4个月前
已完结
A pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine)-decorated liposome system for protein delivery: An application for bladder cancer treatment
4个月前
已完结
皖公网安备34019202002308
